{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:38:23Z","timestamp":1785548303401,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clindermatol.2023.03.007","type":"journal-article","created":{"date-parts":[[2023,3,4]],"date-time":"2023-03-04T18:29:55Z","timestamp":1677954595000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The role of lipids in vitiligo and schizophrenia"],"prefix":"10.1016","volume":"41","author":[{"given":"Caroline","family":"Stamu-O'Brien","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kroumpouzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2023.03.007_bib0001","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000508868","article-title":"A review of skin disease in schizophrenia","volume":"237","author":"McPhie","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0002","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ajp.2017.04.018","article-title":"Pattern and prevalence of psychiatric disorders among patients attending dermatology OPD","volume":"29","author":"Raikhy","year":"2017","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0003","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4103\/psychiatry.IndianJPsychiatry_156_18","article-title":"A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital","volume":"60","author":"George","year":"2018","journal-title":"Indian J Psychiatry"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/jdv.15255","article-title":"Association of vitiligo with hospitalization for mental health disorders in US adults","volume":"33","author":"Patel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0005","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","article-title":"A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis","volume":"171","author":"Benros","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0006","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fendo.2018.00197","article-title":"Neural and endocrinal pathobiochemistry of vitiligo: comparative study for a hypothesized mechanism","volume":"9","author":"Kotb El-Sayed","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0007","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/js.2019-00053","article-title":"Neuroendocrine regulation of brain cytokines after psychological stress","volume":"3","author":"Johnson","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0008","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1196\/annals.1391.013","article-title":"Stress sensitization in schizophrenia","volume":"1113","author":"Yuii","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0009","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08830185.2019.1645138","article-title":"The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases","volume":"38","author":"Chen","year":"2019","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.jid.5700700","article-title":"Membrane lipid alterations as a possible basis for melanocyte degeneration in vitiligo","volume":"127","author":"Dell'Anna","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0011","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fnins.2020.00784","article-title":"Reduced levels and disrupted biosynthesis pathways of plasma free fatty acids in first-episode antipsychotic-na\u00efve cchizophrenia patients","volume":"14","author":"Zhou","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1440-1614.2001.01021.x","article-title":"Implications of lipid biology for the pathogenesis of schizophrenia","volume":"36","author":"Berger","year":"2002","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0013","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0076-6879(02)44709-X","article-title":"Role of G protein beta gamma complex in receptor-G protein interaction","volume":"344","author":"Azpiazu","year":"2002","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0014","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000441540","article-title":"Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients","volume":"49","author":"van Smeden","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0015","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5507\/bp.2011.038","article-title":"Fatty acids as biocompounds: their role in human metabolism, health and disease\u2013a review. Part 1: classification, dietary sources and biological functions","volume":"155","author":"Tvrzicka","year":"2011","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4419-6741-1_1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","volume":"688","author":"Gault","year":"2010","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0017","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.chemphyslip.2016.05.003","article-title":"The role of cholesterol in membrane fusion","volume":"199","author":"Yang","year":"2016","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0018","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0019","first-page":"e14029","article-title":"Vitiligo: the association with metabolic syndrome and the role of simvastatin as an immunomodulator","volume":"13","author":"Verma","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0020","first-page":"163","article-title":"The psychological aspects of vitiligo","volume":"73","author":"Silvan","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0021","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial effects of vitiligo: a systematic literature review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0022","first-page":"56180","article-title":"Vitiligo: a review of some facts lesser known about depigmentation","author":"Nordlund","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0023","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/med.21754","article-title":"Mechanisms of melanocyte death in vitiligo","volume":"41","author":"Chen","year":"2021","journal-title":"Med Res Rev"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.5455\/ijmsph.2016.1008201590","article-title":"Evaluation of oxidative stress and lipid profile in patients of generalized vitiligo","volume":"5","author":"Metta","year":"2016","journal-title":"Int J Med Sci Public Health"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0025","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3164\/jcbn.2008044","article-title":"Increasing oxidative stress with progressive hyperlipidemia in human: relation between malondialdehyde and atherogenic index","volume":"43","author":"Yang","year":"2008","journal-title":"J Clin Biochem Nutr"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0026","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/ijpvm.IJPVM_47_17","article-title":"Role of fatty acids intake in generalized vitiligo","volume":"10","author":"Derakhshandeh-Rishehri","year":"2019","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0027","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abd.2021.04.014","article-title":"Fatty acid-binding protein 4 circulating levels in non-segmental vitiligo","volume":"97","author":"Farag","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-012-2737-4","article-title":"Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?","volume":"56","author":"Kralisch","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0029","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/jcp.22027","article-title":"Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients","volume":"223","author":"Dell'Anna","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.abd.2019.07.006","article-title":"Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study","volume":"95","author":"Tanacan","year":"2020","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0031","first-page":"19","article-title":"Hepato-splenic and lipid profile abnormalities\u2014do they exist in children affected with vitiligo?","volume":"22","author":"Pietrzak","year":"2014","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"3","author":"No\u00ebl","year":"2004","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0033","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.7754\/Clin.Lab.2020.200120","article-title":"Lipid risk factors in vitiligo: homocysteine the connecting link?","volume":"66","author":"Taneja","year":"2020","journal-title":"Clin Lab"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0034","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4088\/JCP.13078co8c","article-title":"Schizophrenia: mechanism of action of current and novel treatments","volume":"75","author":"Correll","year":"2014","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.dsx.2015.04.004","article-title":"Levels of triglycerides, cholesterol, LDL, HDL and glucose in patients with schizophrenia, unipolar depression and bipolar disorder","volume":"9","author":"Wysokinski","year":"2015","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.clindermatol.2023.03.007_bib0036","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1093\/schbul\/sbx021.033","article-title":"A potential role of plasma free fatty acids in schizophrenia pathology","volume":"43","author":"Zhou","year":"2017","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41537-022-00214-2","article-title":"Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi- versus first-episode schizophrenia","volume":"8","author":"Li","year":"2022","journal-title":"NPJ Schizophr"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0038","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1093\/schbul\/sbac011","article-title":"Impaired membrane lipid homeostasis in schizophrenia","volume":"48","author":"Li","year":"2022","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0039","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12944-020-01337-0","article-title":"Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms","volume":"19","author":"Hsu","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1053\/jlts.2001.0070559","article-title":"Statins as immunosuppressive agents","volume":"7","author":"Kobashigawa","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0041","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/denthyp.denthyp_60_19","article-title":"Possible role of statins on the inflammatory biomarkers in patients with periodontal disease: a cross-sectional study","volume":"10","author":"Kadhim","year":"2019","journal-title":"Dental Hypotheses"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0042","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jid.2017.01.020","article-title":"Simvastatin protects human melanocytes from H2O2-induced oxidative stress by activating Nrf2","volume":"137","author":"Chang","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0043","doi-asserted-by":"crossref","DOI":"10.1161\/01.CIR.0000138743.09012.93","article-title":"Antioxidant effects of statins via Snitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins","volume":"110","author":"Haendeler","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0044","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jamadermatol.2017.6401","article-title":"Atorvastatin in combination with narrowband UV-B in adult patients with active vitiligo: a randomized clinical trial","volume":"154","author":"Nguyen","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0045","doi-asserted-by":"crossref","first-page":"223ra23","DOI":"10.1126\/scitranslmed.3007811","article-title":"CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo","volume":"6","author":"Rashighi","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2012.02.015","article-title":"Simvastatin ointment, a new treatment for skin inflammatory conditions","volume":"66","author":"Adami","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0047","first-page":"43","article-title":"Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia","volume":"22","author":"Hanssens","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0048","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fpsyt.2019.00103","article-title":"Statins and inflammation: new therapeutic opportunities in psychiatry","volume":"10","author":"Kim","year":"2019","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0049","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.schres.2014.08.021","article-title":"A randomized placebo-controlled pilot study of pravastatin as an adjunctive therapy in schizophrenia patients: effect on inflammation, psychopathology, cognition and lipid metabolism","volume":"159","author":"Vincenzi","year":"2014","journal-title":"Schizophr Res"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.psychres.2018.02.018","article-title":"Adjunctive therapy with statins in schizophrenia patients: a meta-analysis and implications","volume":"262","author":"Shen","year":"2018","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.clindermatol.2023.03.007_bib0051","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/schbul\/sbab010","article-title":"Simvastatin augmentation for patients with early-phase schizophrenia-spectrum disorders: a double-blind, randomized placebo-controlled trial","volume":"47","author":"Sommer","year":"2021","journal-title":"Schizophr Bull"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X23000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:21:24Z","timestamp":1760034084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X23000342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0738081X23000342"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.03.007","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of lipids in vitiligo and schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2023.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}